Skip to main content
Contact Us
Subscribe
E-Edition
28°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bio-Rad Laboratories
(NY:
BIO
)
332.28
-6.49 (-1.92%)
Official Closing Price
Updated: 7:00 PM EST, Dec 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Bio-Rad Laboratories
< Previous
1
2
3
4
5
6
Next >
Bio-Rad’s Management to Host Investor Meetings at Citi's 2024 Global Healthcare Conference
November 21, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad's Management to Participate in Fireside Chat During UBS Global Healthcare Conference
October 31, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Reports Third-Quarter 2024 Financial Results
October 30, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad to Report Third Quarter 2024 Financial Results on Wednesday, October 30, 2024
October 14, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Expert Ratings For Bio-Rad Laboratories
October 01, 2024
Via
Benzinga
Triple-Witch Says, “Remember Me?”
September 20, 2024
Via
Talk Markets
S&P 500 Shake-Up: New Entrants Driving Market Momentum
September 24, 2024
The quarterly rebalancing of the S&P 500 reflects market capitalization and performance shifts, highlighting growth and challenges in multiple sectors.
Via
MarketBeat
Topics
Artificial Intelligence
Stocks
Exposures
Artificial Intelligence
US Equities
Palantir Stock Will Join the S&P 500 in September. History Says It Could Soar Afterward.
September 13, 2024
History says Palantir stock could soar after its inclusion in the S&P 500.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Palantir Stock Soars After S&P 500 Inclusion, AI Deal With BP Fuels Additional Gains – What's Next?
September 09, 2024
Palantir (PLTR) stock surges due to inclusion in S&P 500 on Sept. 23 and new enterprise deal with BP. Technicals also show bullish trend.
Via
Benzinga
Topics
Artificial Intelligence
Stocks
Exposures
Artificial Intelligence
US Equities
Palantir, Dell Will Join The S&P 500. The AI Stocks Are Jumping.
September 06, 2024
Palantir, Dell Technologies and Erie Indemnity will join the S&P 500 on Sept. 23. All three stocks jumped late Friday.
Via
Investor's Business Daily
Topics
Artificial Intelligence
Stocks
Exposures
Artificial Intelligence
US Equities
The Analyst Landscape: 4 Takes On Bio-Rad Laboratories
May 08, 2024
Via
Benzinga
Bio-Rad’s Management to Participate in Fireside Chat During Wells Fargo’s 2024 Healthcare Conference
August 22, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Appoints Jon DiVincenzo President, Chief Operating Officer
August 20, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Reports Second-Quarter 2024 Financial Results
August 01, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad to Report Second Quarter Financial Results on Thursday, August 1, 2024
July 17, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
S&P 500 Ends First Half Shy Of All-Time Highs. Here Are The Leaders And Laggards — And 5 Stocks That Could Outperform In Next 6 Months
June 30, 2024
The market's resilient run has made traders cautious of a potential correction, but analysts remain optimistic about its trajectory.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
OncoCyte’s (NASDAQ:OCX) Innovative Approach: Potential in Precision Diagnostics
June 05, 2024
Via
AB Newswire
OncoCyte's Innovative Approach: Potential in Precision Diagnostics
June 05, 2024
Chronic conditions such as organ transplant rejection and cancer represent significant challenges in modern healthcare, demanding precise diagnostic tools for effective management and treatment. For...
Via
TheNewswire.com
Bio-Rad Names Anette Engelhardt Executive Vice President and President of Clinical Diagnostics Group
May 30, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad’s Management to Participate in Fireside Chat During Jefferies Global Healthcare Conference
May 23, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
BIO Stock Earnings: Bio-Rad Laboratories Beats EPS, Misses Revenue for Q1 2024
May 07, 2024
BIO stock results show that Bio-Rad Laboratories beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Bio-Rad Reports First-Quarter 2024 Financial Results
May 07, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad’s Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference
May 01, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Announces Life Science Group Management Changes
April 26, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
96% Of S&P 500 Stocks Show Upside Potential Vs. Street Estimates: Which Offers The Best Opportunity?
April 18, 2024
480 out of 500 S&P 500 companies are trading below analysts' price targets, indicating potential profit opportunities. April has been bleak for the market, but some undervalued stocks may be worth...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
April 18, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad’s Chief Operating Officer Andrew Last to Retire
April 10, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial Officer
March 20, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad to Participate in Fireside Chat During Citi's 2024 Unplugged Medtech and Life Sciences Access Day
February 22, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Tech Stocks Ease On Hot PPI, Yields Rise, Microsoft, Amazon Snap 5-Week Positive Streak: What's Driving Markets Friday?
February 16, 2024
Wall Street takes pause after stronger-than-expected producer inflation report, potentially delaying Fed rate cuts and impacting major indices and stocks.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.